EBUS-TBNA vs EUS-B-FNA for Needle Aspiration of Mediastinal Lesions
Launched by ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI · Mar 8, 2016
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
Objectives
Primary objective:
Comparison of Proportion of Adequate and Diagnostic Aspirates in the EUS-B-FNA versus EBUS-TBNA arms as the primary approach for mediastinal fine needle aspiration during Convex probe EBUS.
Secondary objectives
1. Topical Anaesthetic requirement between the two groups
2. Intravenous Sedative / analgesic requirement between the two groups
3. Operator rated overall procedure satisfaction (VAS)
4. Operator rated cough (VAS)
5. Overall duration of procedure Methods Study Design: Prospective randomised study. Sample Size: Number of Patients: 100 (50 -EBUS-TBNA a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years and Older
- • Predominant Subcarinal or Lower Left paratracheal located mediastinal lymphadenopathy/mediastinal lesions at least \>1cm in Short axis diameter.
- • Patients who give consent
- Exclusion Criteria:
- • Refusal of consent for the procedure
- • Any contraindications to Bronchoscopy / Endobronchial Ultrasound
- • Pregnancy
About All India Institute Of Medical Sciences, New Delhi
The All India Institute of Medical Sciences (AIIMS) in New Delhi is a premier medical research institution and a leading clinical trial sponsor in India. Renowned for its commitment to advancing healthcare through innovative research, AIIMS plays a pivotal role in conducting high-quality clinical trials across various medical disciplines. The institute is dedicated to enhancing patient care by integrating cutting-edge scientific research with clinical practice, ensuring rigorous adherence to ethical standards and regulatory guidelines. With a team of expert researchers and state-of-the-art facilities, AIIMS fosters collaboration and knowledge exchange to address pressing health challenges and contribute to global medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, , India
Patients applied
Trial Officials
Randeep Guleria
Study Chair
All India Institute of Medical Sciences, New Delhi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials